Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 271 papers

Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties

Beiert T, Knappe V, Tiyerili V, Stöckigt F, Effelsberg V, Linhart M, Steinmetz M, Klein S, Schierwagen R, Trebicka J, Roell W, Nickenig G, Schrickel JW, Andrié RP

Int J Cardiol 2018, 250: 21–28

DOI: 10.1016/j.ijcard.2017.09.017

Copeptin in acute decompensation of liver cirrhosis: Relationship with acute-on-chronic liver failure and short-term survival

Kerbert AJC, Verspaget HW, Navarro ÀA, Jalan R, Solà E, Benten D, Durand F, Ginès P, van der Reijden JJ, van Hoek B, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Crit Care 2017, 21(1):321

DOI: 10.1186/s13054-017-1894-8

Pro-resolving actions of SPM in adipose tissue biology

Clària J, López-Vicario C, Rius B, Titos E.

Mol Aspects Med 2017, 58: 83–92

DOI: 10.1016/j.mam.2017.03.004

Mouse and rat models of induction of hepatic fibrosis and assessment of portal hypertension

Klein S, Schierwagen R, Uschner FE, Trebicka J.

Methods Mol Biol 2017, 1627: 91–116. In Fibrosis: Methods and Protocols. Rittié L, Ed. Springer Protocols, Humana New York, NY, 22 August 2027.

DOI: 10.1007/978-1-4939-7113-8_7

Sepsis in alcohol-related liver disease

Gustot T, Fernandez J, Szabo G, Albillos A, Louvet A, Jalan R, Moreau R, Moreno C.

J Hepatol 2017, 67(5): 1031–1050

DOI: 10.1016/j.jhep.2017.06.013

Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation

Gustot T, Agarwal B.

J Hepatol 2017, 67(4): 667–668

DOI: 10.1016/j.jhep.2017.07.017

Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure — A retrospective analysis

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med 2017, 45(10): 1616—1624

DOI: 10.1097/CCM.0000000000002562

Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology 2017, 66(4): 1232—1241

DOI: 10.1002/hep.29290

Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: Evidence for a nonfunctional mechanism of hepatorenal syndrome

Arroyo V.

Hepatol Int 2017, 11(3): 242—244

DOI: 10.1007/s12072-017-9784-3

Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis

Kerbert AJ, Schaapman JJ, van der Reijden JJ, Amorós Navarro À, McCormick A, van Hoek B, Arroyo V, Ginès P, Jalan R, Vargas V, Stauber R, Verspaget HW, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Eur J Gastroenterol Hepatol, 29(5): 535—538

DOI: 10.1097/MEG.0000000000000834

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024